Medication Table
| Drug Name | NDC | Description |
|---|---|---|
| Tirzepatide | 26576239 | Injectable medication that acts as a dual agonist for GIP(glucose dependent insulinotropic polypeptide) and GLP-1(gulcagon-like peptide-1) receptors |
| Disprin | 75383793 |
Cures sever Headache |
| Semaglutide | 35543786 | a once-daily oral medication used to improve blood sugar control in adults with type 2 diabetes, often aiding in weight loss |
Tirzepatide
| Description | Injectable medication that acts as a dual agonist for GIP(glucose dependent insulinotropic polypeptide) and GLP-1(gulcagon-like peptide-1) receptors |
| Client | John doe, Brain Gold |
| Drug Name | Tirzepatide |
| Dosage | 2.5 mg |
| Ndc | 26576239 |
| Image |
|
| Upload attachment | Download |
| Product Path | https://www.heurohealth.com/ |
Protocols / Instructions
| Medication | Client | Title | Instructions |
|---|---|---|---|
| Tirzepatide | John doe | Dosage/Timing | Inject on the same day each week, at any time of day, with or without food. Administer in the abdomen, thigh, or upper arm, rotating sites with each injection to minimize skin irritation.
|
